Health Products

SISU L-Arginine 750mg

· Published by Health Canada · Official notice

Details

Alert type: Recall
Category: Drugs
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCommon nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
55773, 47044SISU L-Arginine 750mg
Recalling Firm
Sisu Inc. 104A - 3430 Brighton Avenue Burnaby, British Columbia V5A 3H4
Marketing Authorization Holder
Sisu Inc. 104A - 3430 Brighton Avenue Burnaby, British Columbia V5A 3H4
Capsule80000156750 mg / Capsule

Reason

The Natural Health Products Directorate (NHPD) has issued letters to all L-arginine product licence holders dated March 31, 2006, advising of new information published in the Journal of the American Medical Association of possible increased mortality in patients taking natural health products containing L-arginine, when sold as a single ingredient, following an acute myocardial infarction. NHPD no longer considers theses products safe for consumers with cardiovascular diseases and related disorders without a contraindication warning statements on the label. The recommended contraindication is to state, “ Do not use if you have had a myocardial infarction (heart attack)”.

Depth of distribution

Distributed across Canada.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime